Skip to main content

Actinic Keratosis clinical trials at UC Cancer

1 research study open to eligible people

Showing trials for
  • Comparing Immune Responses to Topical Imiquimod

    open to eligible people ages 18-85

    The study is a basic science research study that is designed to characterize and compare the immune response in individuals who are designated as ABO blood group secretors, meaning they have a functional copy of the FUT2 gene versus those patients who are designated ABO non-secretors after application of topical imiquimod to these patients.

    at UC Davis

Our lead scientists for Actinic Keratosis research studies include .

Last updated: